Cargando…

Potential options for managing LOX+ ER− breast cancer patients

Overexpression of lysyl oxidase (LOX) is often observed in estrogen receptor negative (ER–) breast cancer patients with bone metastasis. In the present bioinformatics study, we observed that LOX is a prognostic factor for poor progression free survival in patients with ER– breast cancer. LOX overexp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Yong, Lian, Shenyi, Cui, Xingran, Meng, Kexin, Győrffy, Balázs, Jin, Tao, Huang, Dongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078060/ https://www.ncbi.nlm.nih.gov/pubmed/27147578 http://dx.doi.org/10.18632/oncotarget.9073

Ejemplares similares

FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
por: Ai, Chao, et al.
Publicado: (2020)

Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
por: Menyhárt, Otília, et al.
Publicado: (2020)

Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023)

Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019)

Unsaturated FAs prevent palmitate-induced LOX-1 induction via inhibition of ER stress in macrophages
por: Ishiyama, Junichi, et al.
Publicado: (2011)

The potential for targeting extracellular LOX proteins in human malignancy
por: Mayorca-Guiliani, Alejandro, et al.
Publicado: (2013)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

New Mouse Lines for the Analysis of Neuronal Morphology Using CreER(T)/loxP-Directed Sparse Labeling
por: Badea, Tudor C., et al.
Publicado: (2009)

Characterization of Genetic Diversity and Linkage Disequilibrium of ZmLOX4 and ZmLOX5 Loci in Maize
por: De La Fuente, Gerald N., et al.
Publicado: (2013)

PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer
por: Xu, Huiyu, et al.
Publicado: (2017)

Potential Involvement of LOX-1 in Functional Consequences of Endothelial Senescence
por: Khaidakov, Magomed, et al.
Publicado: (2011)

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
por: Győrffy, Balázs
Publicado: (2021)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

LOX-1 in Ischemic Stroke
por: Sawamura, Tatsuya, et al.
Publicado: (2017)

Lox’d in translation: contradictions in the nomenclature surrounding common lox-site mutants and their implications in experiments
por: Shaw, Daniel, et al.
Publicado: (2020)

Identification of the LOX Gene Family in Peanut and Functional Characterization of AhLOX29 in Drought Tolerance
por: Mou, Yifei, et al.
Publicado: (2022)

Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer
por: Vendrell, Julie A., et al.
Publicado: (2019)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

LOX-1: A potential driver of cardiovascular risk in SLE patients
por: Sagar, Divya, et al.
Publicado: (2020)

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
por: Gu, Lei, et al.
Publicado: (2013)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis
por: Mihály, Zsuzsanna, et al.
Publicado: (2013)

Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides
por: Hu, Wei, et al.
Publicado: (2017)

Utilizing the LoxP-Stop-LoxP System to Control Transgenic ABC-Transporter Expression In Vitro
por: Esobi, Ikechukwu, et al.
Publicado: (2022)

Healthy hearts lay off LOX
por: Maxmen, Amy
Publicado: (2009)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

LOX-1 and Angiotensin Receptors, and Their Interplay
por: Wang, Xianwei, et al.
Publicado: (2011)

LOX-1 and cancer: an indissoluble liaison
por: Murdocca, M., et al.
Publicado: (2021)

MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1
por: Dai, Yao, et al.
Publicado: (2018)

Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer
por: Bottai, Giulia, et al.
Publicado: (2017)

Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015)

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
por: Saatci, Ozge, et al.
Publicado: (2020)

Survival analysis in breast cancer using proteomic data from four independent datasets
por: Ősz, Ágnes, et al.
Publicado: (2021)

Oxidized LDL and LOX-1 in Experimental Sepsis
por: Al-Banna, Nadia, et al.
Publicado: (2013)

LOX-1: Implications in atherosclerosis and myocardial ischemia
por: Sharma, Tanya, et al.
Publicado: (2022)

Be mindful of potential pitfalls when using the Cre-LoxP system in cancer research
por: Czarnota, Piotr, et al.
Publicado: (2023)

BP1 Homeoprotein Enhances Metastatic Potential in ER-negative Breast Cancer
por: Fu, Yebo, et al.
Publicado: (2010)

Identification of a novel enzyme from E. pacifica that acts as an eicosapentaenoic 8R-LOX and docosahexaenoic 10R-LOX
por: Yuki, Sayaka, et al.
Publicado: (2020)

LoxTnSeq: random transposon insertions combined with cre/lox recombination and counterselection to generate large random genome reductions
por: Shaw, Daniel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7j6pahunqilc2fu9jq4irpo2s2